Skip to content

European Journal of Pharmacology

ISSN 1879-0712, 0014-2999

180 papers in the library · 3,125 citations · publishing 1977-2026

Papers

Sort Most recent Most cited

Influence of adrenalectomy on the gut microbiome and MDMA-induced hyperthermia.

European Journal of Pharmacology April 15, 2023 Amal Aburahma, Srishti Rana, Ray A. Larsen et al. 5 citations

The increased use of the stimulant drug, 3,4-methylenedioxymethamphetamine (MDMA), more commonly known as Ecstasy, Molly or X, has been linked to the development of life-threatening hyperthermia in human and animal models. The current study aimed to investigate the role of the gut-adrenal axis in MDMA-induced hyperthermia by assessing the influence of the acute exogenous supplementation with...

Esketamine ameliorates post-stroke anxiety by modulating microglial HDAC3/NF-κB/COX1 inflammatory signaling in ischemic cortex.

European Journal of Pharmacology March 28, 2023 Ailing Huang, Yang Chen, Shaoshuang Wang et al.

Post-stroke anxiety (PSA) is a kind of affective disorder occurring after a stroke, with anxiety as the primary clinical manifestation. PSA's mechanism is unclear, and there are few prevention and treatment measures. Our previous study found that HDAC3 could activate NF-κB signaling through mediated p65 deacetylation, which further influenced microglia activation. That implies HDAC3 may be the...

DOI: 10.1016/j.ejphar.2023.175667 (opens in new tab) Esketamine Microglia Animals Mice, inbred c57bl +6

Role of 5-HT1A receptors in the basolateral amygdala on 3,4-methylenedioxymethamphetamine-induced prosocial effects in mice.

European Journal of Pharmacology March 10, 2023 Hirohito Esaki, Yuki Sasaki, Naoya Nishitani et al.

3,4-methylenedioxymethamphetamine (MDMA), a recreational drug, induces euphoric sensations and psychosocial effects, such as increased sociability and empathy. Serotonin, also called 5-hydroxytryptamine (5-HT), is a neurotransmitter that has been associated with MDMA-induced prosocial effects. However, the detailed neural mechanisms remain elusive. In the present study, we investigated whether...

DOI: 10.1016/j.ejphar.2023.175653 (opens in new tab) MDMA Animals Mice, inbred icr N-methyl-3,4-methylenedioxyamphetamine +8

(+)-Catharanthine and (-)-18-methoxycoronaridine induce antidepressant-like activity in mice by differently recruiting serotonergic and norepinephrinergic neurotransmission.

European Journal of Pharmacology December 19, 2022 Hugo R Arias, Philippe De Deurwaerdère, Ali El-Kasaby et al.

The antidepressant-like activity of (+)-catharanthine and (-)-18-methoxycoronaridine [(-)-18-MC] was studied in male and female mice using forced swim (FST) and tail suspension tests (TST). The underlying molecular mechanism was assessed by electrophysiological, radioligand, and functional experiments. The FST results showed that acute administration (40 mg/kg) of (+)-catharanthine or (-)-18-MC...

S-ketamine exerts sex- and dose-dependent anti-compulsive-like effect as monotherapy or in augmentation to fluoxetine.

European Journal of Pharmacology November 1, 2022 Júlia Grigorini Mori Ayub, C. Tosta, Breno Lopes Macedo et al.

Since a significant body of studies supports the involvement of glutamatergic neurotransmission in the neurobiology of obsessive-compulsive disorder (OCD). Ketamine, a glutamate N-methyl-D-aspartate (NMDA) receptor antagonist with rapid and sustained antidepressant effect, raises as a potential new anti-OCD drug. Evidence from pre-clinical studies indicates that female mice are more sensitive...

Ecstasy (3,4-methylenedioxymethamphetamine): cardiovascular effects and mechanisms.

European Journal of Pharmacology May 7, 2021 D. Fonseca, D. M. Ribeiro, Margarida Tapadas et al. 23 citations

3,4-methylenedioxymethamphetamine or MDMA (known as "ecstasy") is a recreational drug of abuse, popular worldwide for its distinctive psychotropic effects. Currently, the therapeutic potential of MDMA in psychotherapy has attracted a lot of interest from the scientific community, despite the multitude of effects that this drug of abuse elicits on the human body. While neuronal effects have been...

Pharmacological characterizations of the 'legal high' fluorolintane and isomers.

European Journal of Pharmacology August 15, 2019 Jason Wallach, Tristan Colestock, Julià Agramunt et al.

1,2-Diarylethylamines represent a class of molecules that have shown potential in the treatment of pain, epilepsy, neurodegenerative disease and depression. Examples include lefetamine, remacemide, and lanicemine. Recently, several 1,2-diarylethylamines including the dissociatives diphenidine, methoxphenidine and ephenidine as well as the opioid MT-45, have appeared as 'research chemicals' or...

Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives).

European Journal of Pharmacology July 1, 2019 Dino Luethi, R. Widmer, Daniel Trachsel et al. 18 citations

Many ring-substituted phenethylamines exert psychedelic effects that are thought to be primarily mediated by interactions with serotonergic 5-hydroxytryptamine 2 (5-HT2A) receptors. The 2,5-dimethoxyphenethylamine (2C derivative) core structure with small lipophilic substituents at the 4-position seems to be particularly favorable for psychedelic effects. In contrast, 2C derivatives with bulky...

3,4‐Methylenedioxymethamphetamine, mephedrone, and &bgr;‐phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake

European Journal of Pharmacology October 1, 2018 G. Zsilla, Daniella E Hegyi, M. Baranyi et al.

ABSTRACT The addiction‐related behavioural effects of drugs of abuse are mediated by the mesocorticolimbic monoamine systems. We investigated the effects of 3,4‐methylenedioxymethamphetamine (MDMA), mephedrone, &bgr;‐phenylethylamine (&bgr;‐PEA) methylphenidate (MPH) on dopamine release from mouse perfused nucleus accumbens and prefrontal cortex slices. The fractional release of [3H]‐dopamine...

Endocannabinoid system, stress and HPA axis.

European Journal of Pharmacology September 1, 2018 Vincenzo Micale, Filippo Drago

The endocannabinoid system (ECS), which is composed of the cannabinoid receptors types 1 and 2 (CB1 and CB2) for marijuana's psychoactive ingredient ∆9-tetrahydrocannabinol (∆9-THC), the endogenous ligands (AEA and 2-AG) and the enzymatic systems involved in their biosynthesis and degradation, recently emerged as important modulator of emotional and non-emotional behaviors. In addition to its...

Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems

European Journal of Pharmacology December 8, 2017 Dino Luethi, Marius C. Hoener, Matthias E. Liechti 41 citations

Diclofensine, diphenidine, and methoxphenidine are new psychoactive substances (NPSs) that recently appeared on the illicit drug market. Pharmacological profiling of such newly emerged drugs is crucial for a better understanding of their psychotropic effects and toxicity. We therefore investigated the potential of these NPSs to inhibit the norepinephrine, dopamine, and serotonin transporters in...

DOI: 10.1016/j.ejphar.2017.12.012 (opens in new tab) Monoaminergic Monoamine neurotransmitter Pharmacology Norepinephrine transporter +5

Serotonin 2A receptor disulfide bridge integrity is crucial for ligand binding to different signalling states but not for its homodimerization.

European Journal of Pharmacology November 15, 2017 Alba Iglesias, Marta Cimadevila, Rocío Ailim de La Fuente et al.

The serotonin 2A (5-HT2A) receptor is a G-protein coupled receptor (GPCR) with a conserved disulfide bridge formed by Cys148 (transmembrane helix 3, TM3) and Cys227 (extracellular loop 2, ECL-2). We hypothesized that disulfide bridges may determine serotonin 5-HT2A receptor functions such as receptor activation, functional selectivity and ligand recognition. We used the reducing agent...

DOI: 10.1016/j.ejphar.2017.09.011 (opens in new tab) Full text (opens in new tab) Clozapine pubchem cid Dl-1,4-dithiothreitol pubchem cid Disulfide bridges Phospholipase a2 +4

22-azidosalvinorin A exhibits antidepressant-like effect in mice.

European Journal of Pharmacology April 5, 2017 James Oluwagbamigbe Fajemiroye, Polepally Reddy Prabhakar, Luiz Carlos da Cunha et al.

The increasing cases of depression has made the searches for new drugs and understanding of the underligning neurobiology of this psychiatric disorder a necessity. Here, we modified the structure of salvinorin A (a known halucinogen) and investigated antidepressant-like activity of its four derivatives; 22-methylsulfanylsalvinorin A(SA1), 2-O-cinnamoylsalvinorin B (CSB), 22-azidosalvinorin A...

MDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors.

European Journal of Pharmacology August 15, 2015 Stuart A. Collins, Gary A. Gudelsky, Bryan K. Yamamoto

MDMA is a widely abused psychostimulant which causes a rapid and robust release of the monoaminergic neurotransmitters dopamine and serotonin. Recently, it was shown that MDMA increases extracellular glutamate concentrations in the dorsal hippocampus, which is dependent on serotonin release and 5HT2A/2C receptor activation. The increased extracellular glutamate concentration coincides with a...

Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.

European Journal of Pharmacology August 15, 2014 Jenny L Wiley, D Matthew Walentiny, M Jerry Wright et al.

The mechanism through which marijuana produces its psychoactive effects is Δ(9)-tetrahydrocannabinol (THC)-induced activation of cannabinoid CB1 receptors. These receptors are normally activated by endogenous lipids, including anandamide and 2-arachidonoyl glycerol (2-AG). A logical "first step" in determination of the role of these endocannabinoids in THC׳s psychoactive effects is to...

DOI: 10.1016/j.ejphar.2014.05.013 (opens in new tab) Full text (opens in new tab) 2-arachidonoylglycerol Anandamide Jzl184 Pf3845 +2

The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys.

European Journal of Pharmacology March 15, 2014 Lenka Hruba, Lance R Mcmahon

Synthetic cannabinoid abuse and case reports of adverse effects have raised concerns about the pharmacologic mechanisms underlying in vivo effects. Here, a synthetic cannabinoid identified in abused products (HU-210) was compared to the effects of Δ(9)-THC and two other synthetic cannabinoid agonists used extensively in pre-clinical studies (CP 55,940 and WIN 55,212-2). One group of monkeys...

DOI: 10.1016/j.ejphar.2014.01.041 (opens in new tab) Full text (opens in new tab) Apparent affinity Cannabinoid Drug discrimination Hu-210 +1

Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.

European Journal of Pharmacology March 15, 2014 Luke A. Downey, Jennifer M Loftis

Central nervous system (CNS) damage associated with psychostimulant dependence may be an ongoing, degenerative process with adverse effects on neuropsychiatric function. However, the molecular mechanisms regarding how altered energy regulation affects immune response in the context of substance use disorders are not fully understood. This review summarizes the current evidence regarding the...

DOI: 10.1016/j.ejphar.2014.01.032 (opens in new tab) Full text (opens in new tab) 2-fluoro-2-deoxy-d-glucose pubchem cid 3,4-Methylenedioxy-N-Methylamphetamine MDMA Bioenergetics Cocaine pubchem cid +4

The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats.

European Journal of Pharmacology November 15, 2013 Aashish S Morani, Amy W M Ewald, Katherine M Prevatt-Smith et al.

κ Opioid receptor activation by traditional arylacetamide agonists and the novel neoclerodane diterpene κ opioid receptor agonist Salvinorin A (Sal A) results in attenuation of cocaine-seeking behavior in pre-clinical models of addiction. However, adverse effects such as sedation, depression and aversion limit their clinical utility. The Sal A analogue, 2-methoxy-methyl salvinorin B (MOM Sal B)...

Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs.

European Journal of Pharmacology November 21, 2012 Nicholas V. Cozzi, Simon D. Brandt, Paul F. Daley et al.

Cathinones are a class of drugs used to treat various medical conditions including depression, obesity, substance abuse, and muscle spasms. Some "designer" cathinones, such as methcathinone, mephedrone, and methylone, are used nonclinically for their stimulant or entactogenic properties. Given the recent rise in nonmedical use of designer cathinones, we aimed to improve understanding of...

Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.

European Journal of Pharmacology January 15, 2012 Samanta Yubero‐lahoz, Mario A Ayestas, Bruce E. Blough et al.

(±)-3,4-Methylenedioxymethamphetamine (MDMA) is an illicit drug that evokes transporter-mediated release of serotonin (5-HT) in the brain. 5-HT transporter (SERT) proteins are also expressed in non-neural tissues (e.g., blood), and evidence suggests that MDMA targets platelet SERT to increase plasma 5-HT. Here we tested two hypotheses related to the effects of MDMA on circulating 5-HT. First,...

Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administration.

European Journal of Pharmacology August 19, 2011 Stanley D Glick, Elizabeth M Sell, Sarah E McCallum et al.

18-Methoxycoronaridine (18-MC), a putative anti-addictive agent, has been shown to decrease the self-administration of several drugs of abuse in rats. 18-MC is a potent antagonist at α3β4 nicotinic receptors. Consistent with high densities of α3β4 nicotinic receptors being located in the medial habenula and the interpeduncular nucleus, 18-MC has been shown to act in these regions to decrease...

Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3-4, methylenedioxymethamphetamine (MDMA) in female SD rats

European Journal of Pharmacology April 28, 2011 Pamela B. Yang, Kristal D. Atkins, Nachum Dafny 42 citations

The psychostimulants amphetamine and methylphenidate (MPD / Ritalin) are the drugs most often used to treat attention deficit hyperactivity disorder (ADHD). In addition, students of all ages take these drugs to improve academic performance but also abuse them for pleasurable enhancement. In addition, other psychostimulants such 3,4 methylenedioxymethamphetamine (MDMA / ecstasy) are used /...

The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice.

European Journal of Pharmacology April 10, 2011 D Matthew Walentiny, Thomas F Gamage, Jonathan A Warner et al.

The endogenous cannabinoid system has been noted for its therapeutic potential, as well as the psychoactivity of cannabinoids such as Δ9-tetrahydrocannabinol (THC). However, less is known about the psychoactivity of anandamide (AEA), an endocannabinoid ligand. Thus, the goals of this study were to establish AEA as a discriminative stimulus in transgenic mice lacking fatty acid amide hydrolase...

Antagonism of ∆⁹-THC induced behavioral effects by rimonabant: time course studies in rats.

European Journal of Pharmacology December 1, 2010 Torbjörn U C Järbe, Roger S Gifford, Alexandros Makriyannis

The objective was to examine the time course of the cannabinoid 1 receptor antagonist/inverse agonist rimonabant's ability to antagonize in vivo cannabinergic agonist effects. We used two behavioral procedures sensitive to the effects of ∆⁹-tetrahydrocannabinol (∆⁹-THC): rat drug discrimination (EXP-1) and suppression of fixed-ratio responding (FR) for food reinforcement (EXP-2). Two training...